YAP1 and non-small cell lung carcinoma: These results suggest that YAP/TAZ activity plays a critical role in NSCLC cell proliferation and that statins exert their anticancer effects, at least in part, by inhibiting YAP/TAZ signaling in mesenchymal-like NSCLC cells.